These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
93 related items for PubMed ID: 20058779
1. Travelers on beta-blockers: is malaria chemoprophylaxis dangerous? Abecasis J, Dores H, Arroja I, Santos JM, Silva A. Rev Port Cardiol; 2009 Oct; 28(10):1153-9. PubMed ID: 20058779 [Abstract] [Full Text] [Related]
2. Chemoprophylaxis according to the guidelines on malaria prevention for Japanese overseas travelers. Mizuno Y, Kudo K, Kano S. Southeast Asian J Trop Med Public Health; 2006 Oct; 37 Suppl 3():11-4. PubMed ID: 17547042 [Abstract] [Full Text] [Related]
3. The safety and tolerance of atovaquone/proguanil for the long-term prophylaxis of plasmodium falciparum malaria in non-immune travelers and expatriates [corrected]. van Genderen PJ, Koene HR, Spong K, Overbosch D. J Travel Med; 2007 Oct; 14(2):92-5. PubMed ID: 17367478 [Abstract] [Full Text] [Related]
4. Mefloquine prophylaxis--revisited. Cohen J. Aust Fam Physician; 1997 Aug; 26(8):909. PubMed ID: 9267055 [No Abstract] [Full Text] [Related]
8. [Neuropsychiatric symptoms in preventive antimalarial treatment with mefloquine: apropos of 2 cases]. Lebain P, Juliard C, Davy JP, Dollfus S. Encephale; 2000 Aug; 26(4):67-70. PubMed ID: 11064842 [Abstract] [Full Text] [Related]
9. Malaria chemoprophylaxis advice: survey of South African community pharmacists' knowledge and practices. Toovey S. J Travel Med; 2006 Aug; 13(3):161-5. PubMed ID: 16706947 [Abstract] [Full Text] [Related]
10. Primaquine as prophylaxis for malaria for nonimmune travelers: A comparison with mefloquine and doxycycline. Schwartz E, Regev-Yochay G. Clin Infect Dis; 1999 Dec; 29(6):1502-6. PubMed ID: 10585803 [Abstract] [Full Text] [Related]
12. Malaria prevention in travelers. Juckett G. Am Fam Physician; 1999 May 01; 59(9):2523-30, 2535-6. PubMed ID: 10323359 [Abstract] [Full Text] [Related]
13. Questionnaire-based analysis of mefloquine chemoprophylaxis for malaria in a Japanese population. Matsumura T, Fujii T, Miura T, Koibuchi T, Endo T, Nakamura H, Odawara T, Iwamoto A, Nakamura T. J Infect Chemother; 2005 Aug 01; 11(4):196-8. PubMed ID: 16133712 [Abstract] [Full Text] [Related]
14. Mefloquine--its 20 years in the Thai Malaria Control Program. Wongsrichanalai C, Prajakwong S, Meshnick SR, Shanks GD, Thimasarn K. Southeast Asian J Trop Med Public Health; 2004 Jun 01; 35(2):300-8. PubMed ID: 15691128 [Abstract] [Full Text] [Related]
15. Case study: neuropsychiatric symptoms associated with the antimalarial agent mefloquine. Clattenburg RN, Donnelly CL. J Am Acad Child Adolesc Psychiatry; 1997 Nov 01; 36(11):1606-8. PubMed ID: 9394947 [Abstract] [Full Text] [Related]
16. Controversies and misconceptions in malaria chemoprophylaxis for travelers. Chen LH, Wilson ME, Schlagenhauf P. JAMA; 2007 May 23; 297(20):2251-63. PubMed ID: 17519415 [Abstract] [Full Text] [Related]
19. [Neuropsychiatric symptoms caused by mefloquine (report of several cases)]. Murai Z, Baran B, Tolna J, Szily E, Gazdag G. Orv Hetil; 2005 Jan 16; 146(3):133-6. PubMed ID: 15693445 [Abstract] [Full Text] [Related]
20. [Psychopathological phenomena in long-term follow-up of acute psychosis after preventive mefloquinine (Lariam) administration]. Meszaros K, Kasper S. Nervenarzt; 1996 May 16; 67(5):404-6. PubMed ID: 9005352 [Abstract] [Full Text] [Related] Page: [Next] [New Search]